Post-traumatic stress disorder (PTSD) Mental and Behavioural Disorders Reaction to severe stress, and adjustment disorders
Conditions
Interventions
Participants will enter the trial at 2 - 3 months after a traumatic event. They will either be allocated to active treatment or a wait list.
The experimental intervention will be a course of cognitiv
follow ups will take place at 6 months and 12 months post-treatment.
Sponsors
Medical Research Council (MRC) (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Exposure to a road traffic accident, an assault, or another discrete traumatic stressor (i.e. any event that involve the threat of death, severe injury, or threat to bodily integrity, or witnessing such an event) 2. Aged 8 - 17 years, either sex 3. Meeting Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) diagnostic criteria for PTSD, or the alternative algorthim for children and young people proposed by Scheeringa and colleagues (Scheeringa, Wright, Hunt, & Zeanah, 2006), assessed by a structured interview 4. The index trauma occurred 2 - 3 months prior to trial entry
Exclusion criteria
Exclusion criteria: 1. Intellectual disability (i.e. mental retardation) 2. Another primary psychiatric diagnosis 3. PTSD following another previous trauma 4. Unconscious for greater than 15 minutes following the traumatic event 5. Not being fluent in English 6. Ongoing exposure to threat 7. History of organic brain damage 8. Significant risk of self-harm
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. PTSD status, as assessed using the Children's PTSD Inventory (CPTSDI) 2. Child PTSD Symptom Scale (CPSS) All of the primary and secondary outcome measures will be completed at the pre- and post-treatment assessments; all primary and secondary measures will be completed at the 6- and 12-month follow ups, with the exception of the Clinician's Global Assessment Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Mood and Feelings Questionnaire (MFQ) 2. Spence Children?s Anxiety Scale (SCAS) 3. Children?s Global Assessment Scale (CGAS) All of the primary and secondary outcome measures will be completed at the pre- and post-treatment assessments; all primary and secondary measures will be completed at the 6- and 12-month follow ups, with the exception of the Clinician's Global Assessment Scale. | — |
Countries
United Kingdom
Outcome results
None listed